Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biodesix Inc (BDSX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biodesix Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1439725.
Total stock buying since 2020: $63,273,082.
Total stock sales since 2020: $598,137.
Total stock option exercises since 2020: $1,369,812.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 8,211,611 | $2,818,623 | 158,048 | $139,670 | 630,589 | $0 |
| 2024 | 643,953 | $821,492 | 119,573 | $212,211 | 5,575,213 | $1,767 |
| 2023 | 389,027 | $615,182 | 75,932 | $118,183 | 1,558,953 | $0 |
| 2022 | 28,621,677 | $35,635,386 | 71,482 | $128,073 | 279,760 | $2,385 |
| 2021 | 3,382,322 | $16,042,629 | 0 | $0 | 48,932 | $49,484 |
| 2020 | 407,765 | $7,339,770 | 0 | $0 | 257,957 | $1,316,176 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-09 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 2,512 | 1.57 | 3,933 |
| 2023-05-09 | Hutton Scott (President & CEO) | Sale | 9,934 | 1.57 | 15,556 |
| 2023-05-09 | Siurek Ryan H (Chief Accounting Officer) | Sale | 1,456 | 1.57 | 2,280 |
| 2023-05-08 | O'kane Kieran (Chief Commercial Officer) | Option Ex | 5,461 | .00 | 0 |
| 2023-05-08 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 5,054 | .00 | 0 |
| 2023-05-08 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 11,575 | .00 | 0 |
| 2023-05-08 | Hutton Scott (President & CEO) | Option Ex | 44,778 | .00 | 0 |
| 2023-05-08 | Siurek Ryan H (Chief Accounting Officer) | Option Ex | 5,484 | .00 | 0 |
| 2023-03-31 | Watts Charles M | Option Ex | 301,422 | .00 | 0 |
| 2023-03-31 | Kayyem Jon Faiz | Option Ex | 291,666 | .00 | 0 |
| 2023-03-31 | Massarany Hany | Option Ex | 291,666 | .00 | 0 |
| 2023-02-09 | O'kane Kieran (Chief Commercial Officer) | Sale | 1,999 | 1.80 | 3,596 |
| 2023-02-09 | Pestano Gary Anthony (Chief Development Officer) | Sale | 1,852 | 1.80 | 3,331 |
| 2023-02-09 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 4,220 | 1.80 | 7,591 |
| 2023-02-09 | Hutton Scott (President & CEO) | Sale | 16,278 | 1.80 | 29,284 |
| 2023-02-09 | Siurek Ryan H (Chief Accounting Officer) | Sale | 2,016 | 1.80 | 3,626 |
| 2023-02-08 | O'kane Kieran (Chief Commercial Officer) | Option Ex | 5,461 | .00 | 0 |
| 2023-02-08 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 5,053 | .00 | 0 |
| 2023-02-08 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 11,575 | .00 | 0 |
| 2023-02-08 | Hutton Scott (President & CEO) | Option Ex | 44,777 | .00 | 0 |
| 2023-02-08 | Siurek Ryan H (Chief Accounting Officer) | Option Ex | 5,483 | .00 | 0 |
| 2023-01-31 | Schuler Jack W | Buy | 10,000 | 2.41 | 24,100 |
| 2023-01-27 | Schuler Jack W | Buy | 50,000 | 2.51 | 125,450 |
| 2022-12-16 | Schuler Jack W | Buy | 10,000 | 1.70 | 17,000 |
| 2022-12-12 | Schuler Jack W | Buy | 100,000 | 1.48 | 148,400 |
| 2022-11-21 | Kennedy Lawrence T. Jr | Buy | 10,869,565 | 1.15 | 12,499,999 |
| 2022-11-21 | Watts Charles M | Buy | 43,478 | 1.15 | 49,999 |
| 2022-11-21 | Strobeck Matthew | Buy | 2,669,562 | 1.15 | 3,069,996 |
| 2022-11-21 | Kayyem Jon Faiz | Buy | 173,913 | 1.15 | 199,999 |
| 2022-11-21 | Massarany Hany | Buy | 130,434 | 1.15 | 149,999 |
| 2022-11-21 | Patience John | Buy | 1,739,130 | 1.15 | 1,999,999 |
| 2022-11-21 | Schuler Jack W | Buy | 8,695,652 | 1.15 | 9,999,999 |
| 2022-11-10 | O'kane Kieran (Chief Commercial Officer) | Sale | 753 | 1.02 | 766 |
| 2022-11-10 | Georgantas Robert William Iii (Chief Scientific Officer) | Sale | 785 | 1.02 | 799 |
| 2022-11-10 | Pestano Gary Anthony (Chief Development Officer) | Sale | 698 | 1.02 | 710 |
| 2022-11-10 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 1,583 | 1.02 | 1,611 |
| 2022-11-10 | Hutton Scott (President & CEO) | Sale | 6,087 | 1.02 | 6,196 |
| 2022-11-10 | Siurek Ryan H (Chief Accounting Officer) | Sale | 762 | 1.02 | 775 |
| 2022-11-09 | O'kane Kieran (Chief Commercial Officer) | Sale | 952 | 1.04 | 991 |
| 2022-11-09 | Georgantas Robert William Iii (Chief Scientific Officer) | Sale | 991 | 1.04 | 1,032 |
| 2022-11-09 | Pestano Gary Anthony (Chief Development Officer) | Sale | 882 | 1.04 | 919 |
| 2022-11-09 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 1,999 | 1.04 | 2,082 |
| 2022-11-09 | Hutton Scott (President & CEO) | Sale | 7,690 | 1.04 | 8,012 |
| 2022-11-09 | Siurek Ryan H (Chief Accounting Officer) | Sale | 963 | 1.04 | 1,003 |
| 2022-11-08 | O'kane Kieran (Chief Commercial Officer) | Option Ex | 5,461 | .00 | 0 |
| 2022-11-08 | Georgantas Robert William Iii (Chief Scientific Officer) | Option Ex | 5,646 | .00 | 0 |
| 2022-11-08 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 5,054 | .00 | 0 |
| 2022-11-08 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 11,574 | .00 | 0 |
| 2022-11-08 | Hutton Scott (President & CEO) | Option Ex | 44,778 | .00 | 0 |
| 2022-11-08 | Siurek Ryan H (Chief Accounting Officer) | Option Ex | 5,482 | .00 | 0 |
| 2022-08-09 | O'kane Kieran (Chief Commercial Officer) | Sale | 1,673 | 2.53 | 4,229 |
| 2022-08-09 | Georgantas Robert William Iii (Chief Scientific Officer) | Sale | 1,686 | 2.53 | 4,262 |
| 2022-08-09 | Pestano Gary Anthony (Chief Development Officer) | Sale | 1,549 | 2.53 | 3,915 |
| 2022-08-09 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 3,533 | 2.53 | 8,931 |
| 2022-08-09 | Hutton Scott (President & CEO) | Sale | 13,634 | 2.53 | 34,466 |
| 2022-08-09 | Siurek Ryan H (Chief Accounting Officer) | Sale | 1,645 | 2.53 | 4,158 |
| 2022-08-08 | O'kane Kieran (Chief Commercial Officer) | Option Ex | 5,462 | .00 | 0 |
| 2022-08-08 | Georgantas Robert William Iii (Chief Scientific Officer) | Option Ex | 5,647 | .00 | 0 |
| 2022-08-08 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 5,054 | .00 | 0 |
| 2022-08-08 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 11,575 | .00 | 0 |
| 2022-08-08 | Hutton Scott (President & CEO) | Option Ex | 44,777 | .00 | 0 |
| 2022-08-08 | Siurek Ryan H (Chief Accounting Officer) | Option Ex | 5,484 | .00 | 0 |
| 2022-05-10 | O'kane Kieran (Chief Commercial Officer) | Sale | 1,583 | 1.83 | 2,896 |
| 2022-05-10 | Georgantas Robert William Iii (Chief Scientific Officer) | Sale | 2,004 | 1.83 | 3,667 |
| 2022-05-10 | Pestano Gary Anthony (Chief Development Officer) | Sale | 1,467 | 1.83 | 2,684 |
| 2022-05-10 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Sale | 3,338 | 1.83 | 6,108 |
| 2022-05-10 | Hutton Scott (President & CEO) | Sale | 13,278 | 1.83 | 24,298 |
| 2022-05-10 | Siurek Ryan H (Chief Accounting Officer) | Sale | 1,947 | 1.83 | 3,563 |
| 2022-05-09 | O'kane Kieran (Chief Commercial Officer) | Option Ex | 5,461 | .00 | 0 |
| 2022-05-09 | Georgantas Robert William Iii (Chief Scientific Officer) | Option Ex | 5,647 | .00 | 0 |
| 2022-05-09 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 5,054 | .00 | 0 |
| 2022-05-09 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 11,575 | .00 | 0 |
| 2022-05-09 | Hutton Scott (President & CEO) | Option Ex | 44,778 | .00 | 0 |
| 2022-05-09 | Siurek Ryan H (Chief Accounting Officer) | Option Ex | 5,484 | .00 | 0 |
| 2022-04-07 | Strobeck Matthew | Buy | 1,117,318 | 1.79 | 1,999,999 |
| 2022-04-07 | Patience John | Buy | 279,329 | 1.79 | 499,998 |
| 2022-04-07 | Schuler Jack W | Buy | 2,793,296 | 1.79 | 4,999,999 |
| 2022-03-31 | Franchi Jean M. | Option Ex | 20,044 | .00 | 0 |
| 2022-03-31 | Strobeck Matthew | Option Ex | 20,044 | .00 | 0 |
| 2022-01-13 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 5,679 | .42 | 2,385 |
| 2021-12-30 | Strobeck Matthew | Buy | 295,600 | 4.35 | 1,285,860 |
| 2021-12-30 | Patience John | Buy | 160,919 | 4.35 | 699,997 |
| 2021-12-30 | Schuler Jack W | Buy | 2,298,850 | 4.35 | 9,999,997 |
| 2021-12-20 | Watts Charles M | Buy | 5,855 | 4.29 | 25,129 |
| 2021-11-23 | Patience John | Buy | 10,000 | 6.17 | 61,750 |
| 2021-11-22 | Schuler Jack W | Buy | 20,000 | 6.34 | 126,760 |
| 2021-11-19 | Schuler Jack W | Buy | 60,000 | 6.50 | 390,180 |
| 2021-11-18 | Patience John | Buy | 9,497 | 6.34 | 60,220 |
| 2021-11-18 | Schuler Jack W | Buy | 28,361 | 6.33 | 179,496 |
| 2021-11-17 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Buy | 1,000 | 6.51 | 6,510 |
| 2021-11-17 | Hutton Scott (President & CEO) | Buy | 3,000 | 6.46 | 19,374 |
| 2021-11-17 | Schuler Jack W | Buy | 20,000 | 6.50 | 130,100 |
| 2021-08-19 | Patience John | Buy | 8,396 | 8.04 | 67,487 |
| 2021-08-19 | Schuler Jack W | Buy | 50,000 | 7.69 | 384,450 |
| 2021-08-17 | Patience John | Buy | 1,604 | 7.12 | 11,415 |
| 2021-08-17 | Schuler Jack W | Buy | 29,440 | 7.18 | 211,438 |
| 2021-08-13 | Schuler Jack W | Buy | 232,000 | 7.50 | 1,739,536 |
| 2021-04-05 | Georgantas Robert William Iii (SVP, Rsrch & Trans'l Science) | Option Ex | 10,219 | .77 | 7,868 |
| 2021-04-01 | Cowie Robin Harper (CFO, Sec'y & Treasurer) | Option Ex | 38,713 | 1.07 | 41,616 |
| 2020-12-18 | Pestano Gary Anthony (Chief Development Officer) | Option Ex | 82,166 | 1.41 | 115,525 |
| 2020-12-07 | Strobeck Matthew | Option Ex | 58,597 | 6.83 | 400,217 |
| 2020-12-07 | Patience John | Option Ex | 58,597 | 6.83 | 400,217 |
| 2020-12-07 | Schuler Jack W | Option Ex | 58,597 | 6.83 | 400,217 |
| 2020-10-30 | Georgantas Robert William Iii (SVP, Rsrch & Trans'l Science) | Buy | 655 | 18.00 | 11,790 |
| 2020-10-30 | Cowie Robin Harper (CFO, Sec?y & Treasurer) | Buy | 1,000 | 18.00 | 18,000 |
| 2020-10-30 | Watts Charles M (Director) | Buy | 2,000 | 18.00 | 36,000 |
| 2020-10-30 | Hutton Scott (President & CEO) | Buy | 5,500 | 18.00 | 99,000 |
| 2020-10-30 | Strobeck Matthew (Director) | Buy | 83,333 | 18.00 | 1,499,994 |
| 2020-10-30 | Massarany Hany (Director) | Buy | 7,500 | 18.00 | 135,000 |
| 2020-10-30 | Patience John (Director) | Buy | 30,000 | 18.00 | 540,000 |
| 2020-10-30 | Schuler Jack W (Director) | Buy | 277,777 | 18.00 | 4,999,986 |
Insider trading activities including stock purchases, stock sales, and option exercises of BDSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biodesix Inc (symbol BDSX, CIK number 1439725) see the Securities and Exchange Commission (SEC) website.